Jumpcan Pharma's Unit Gets Nod for Roxadustat Capsules' Registration

MT NewswiresJan 14 12:13

A-shares show unusual activity丨Traditional Chinese Medicine stocks all rose, with Guangdong Zhongsheng Pharmaceutical and several other stocks hitting the daily limit, as the State Council emphasized increasing support for the research and innovation of T

On January 6, in the A-share market, the Traditional Chinese Medicine Sector rose against the trend, with Datang Pharmaceutical rising nearly 19%, Shanghai Kaibao Pharmaceutical rising over 16%, Xiangxue Pharmaceutical rising over 14%, Henan Taloph Pharmaceutical Stock, Shijiazhuang Yiling Pharmaceutical, Hainan Huluwa Pharmaceutical Group, and Guangdong Zhongsheng Pharmaceutical hitting the 10% limit up, Shanghai Shenqi Pharmaceutical Investment Management rising 9%, Jinghua Pharmaceutical Group, Tianjin Chase Sun Pharmaceutical, and Jiangxi Wannianqing Cement rising over 8%, Guizhou Sanli Pharmaceutical Co.,Ltd., Biovalley, and Guizhou Xinbang Pharmaceutical rising over 7%, Shandong Wohua Pharmaceutical and Sunflower Pharmaceutical Group rising over 6%, Zhejiang Xinguang Pharmaceutical, Oukang Pharmaceutical, Gansu Longshenrongfa Pharmaceutical Industry, and Guilin Sanjin Pharmaceutical rising over 5%, Guiyang Xintian Pharmaceutical, Zhejiang Wecome Pharmaceutical, Chongqing Taiji Industry, and Hubei Jumpca

Gelonghui FinanceJan 6 15:20

Hubei Jumpcan Pharmaceutical Gets China Approval for Antibiotics

MT NewswiresDec 13, 2024 14:38

Hubei Jumpcan Pharmaceutical (600566.SH): Subsidiary obtained the Pharmaceutical registration certificate.

On December 12, Gelonghui reported that Hubei Jumpcan Pharmaceutical (600566.SH) announced that its wholly-owned subsidiary, Hubei Jumpcan Pharmaceutical Group Co., Ltd., and Shaanxi Dongke Pharmaceutical Co., Ltd. received the pediatric Faropenem sodium granule "Drug Registration Certificate" and the injectable Cefoperazone Sodium "Drug Registration Certificate" approved by the National Medical Products Administration. The registration of pediatric Faropenem sodium granules is classified as Chemical Drug Class 4, and it was reviewed and approved in accordance with the technical requirements consistent with the quality and efficacy of the reference preparation. Once approved, it is regarded as having passed the consistency evaluation of the quality and efficacy of generic drugs, mainly used for treating pediatric infectious diseases caused by bacteria sensitive to Faropenem.

Gelonghui FinanceDec 12, 2024 17:15

Express News | Hubei Jumpcan Pharmaceutical: Subsidiary has obtained the Pharmaceutical registration certificate.

BreakingsDec 12, 2024 17:15

Express News | Significant progress in domestically produced growth hormone! Hubei Jumpcan Pharmaceutical and i-mab announced that the application for the market launch of Itan long-acting growth hormone has been accepted.

BreakingsDec 10, 2024 10:11